Filing Details
ENDRA Life Sciences Inc. (NASDAQ:NDRA) filed a Form 8-K with the Securities and Exchange Commission on June 25, 2026, disclosing a material event.
8k filedNASDAQ:NDRA
ENDRA Life Sciences Inc. (NDRA) Reports Material Event to SEC
Filing Details ENDRA Life Sciences Inc. (NASDAQ:NDRA) filed a Form 8-K with the Securities and Exchange Commission on June 25, 2026, disclosing a material event. Market Context…
Market Context
ENDRA Life Sciences Inc.'s stock currently trades at $4.30 with a market capitalization of $4.5M. The Healthcare company's stock moved following the disclosure.
8-K filings report material events that shareholders should know about between regular quarterly or annual reports. These can include leadership changes, material agreements, acquisitions, asset sales, or changes to financial guidance. The specific nature of the event determines its significance for ENDRA Life Sciences Inc.'s stock.
All SEC filings for ENDRA Life Sciences Inc. are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View NDRA Stock Page
Frequently Asked Questions
Where can I read NDRA's SEC filings?
Browse all filings on our NDRA SEC filings page.
What types of SEC filings does ENDRA Life Sciences Inc. file?
Public companies like ENDRA Life Sciences Inc. file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.